UM Ventures News
![Rexahn Pharmaceuticals Rexahn Pharmaceuticals](https://www.umventures.org/sites/default/files/styles/medium/public/rexahn_logo.jpg?itok=CPnm_QUd)
Rexahn Initiates Phase Ib Clinical Trial of RX-3117 for Treatment of Solid Tumors
Thursday, January 23, 2014
![Dr. Martha J. Connolly Dr. Martha J. Connolly](https://www.umventures.org/sites/default/files/styles/medium/public/connolly.png?itok=rUOqj93f)
Bioentrepreneurship Leader Joins UM Ventures Team
Friday, January 10, 2014
![PaxVax, Rexahn, and Analytical Informatics PaxVax, Rexahn, and Analytical Informatics](https://www.umventures.org/sites/default/files/styles/medium/public/three-companies.png?itok=Ik4Iaq-7)
Three Companies with UMB Roots Make Progress in Late 2013
Thursday, December 19, 2013
![Jim Hughes featured on BioBuzz Jim Hughes featured on BioBuzz](https://www.umventures.org/sites/default/files/styles/medium/public/biobuzz.png?itok=xWPOcLoo)
Jim Hughes and UM Ventures Featured on BioBuzz
Saturday, November 30, 2013
![Thomas R. Fuerst Thomas R. Fuerst](https://www.umventures.org/sites/default/files/styles/medium/public/thomasfuerst.jpg?itok=_iZTHHfY)
New IBBR Director Envisions Premier Biotechnology Research Institute
Monday, November 25, 2013
Alba Therapeutics Names New CEO
Monday, November 4, 2013
Nobel Laureate Comes to Campus to Share His Love of Science
Sunday, November 3, 2013
![Gliknik Gliknik](https://www.umventures.org/sites/default/files/styles/medium/public/gliknik_logo.png?itok=9zgokTf-)
Gliknik's David Block Among Featured Speakers at Maryland Entrepreneur Breakfast
Tuesday, October 29, 2013